Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) will likely be issuing its results before the market opens on Thursday, August 20th. Analysts expect the company to announce earnings of $0.6050 per share and revenue of $1.2627 billion for the quarter.
Novozymes A/S Price Performance
Novozymes A/S stock opened at $66.56 on Tuesday. The firm has a fifty day simple moving average of $62.61 and a two-hundred day simple moving average of $60.01. Novozymes A/S has a twelve month low of $52.10 and a twelve month high of $67.50.
Novozymes A/S Company Profile
Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.
Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing.
Further Reading
- Five stocks we like better than Novozymes A/S
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
